Yong‐Zhan Zhen
- Topics
- Bioactive Compounds and Antitumor Agents (7 papers)Cancer therapeutics and mechanisms (6 papers)Phytochemistry and biological activity of medicinal plants (6 papers)
- Cited by
- ToxicologyPharmacologyHepatology
- Partner nations
- ChinaTürkiyeUnited States
In The Last Decade
Yong‐Zhan Zhen
31 papers receiving 475 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 212
- Epidemiology 91
- Plant Science 78
- Pharmacology 63
- Oncology 62
Countries citing papers authored by Yong‐Zhan Zhen
This map shows the geographic impact of Yong‐Zhan Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Zhan Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Zhan Zhen more than expected).
Fields of papers citing papers by Yong‐Zhan Zhen
This network shows the impact of papers produced by Yong‐Zhan Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Zhan Zhen. The network helps show where Yong‐Zhan Zhen may publish in the future.
Co-authorship network of co-authors of Yong‐Zhan Zhen
This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Zhan Zhen. A scholar is included among the top collaborators of Yong‐Zhan Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Zhan Zhen. Yong‐Zhan Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 26 | |
| 3 | 3 | |
| 4 | 19 | |
| 5 | 4 | |
| 6 | 32 | |
| 7 | 35 | |
| 8 | 11 | |
| 9 | 25 | |
| 10 | 16 | |
| 11 | Lidamycin inhibits mouse myeloma SP2/0 in vivo and in vitro | 1 |
| 12 | 20 | |
| 13 | 5 | |
| 14 | 7 | |
| 15 | 2 | |
| 16 | 31 | |
| 17 | 9 | |
| 18 | 12 | |
| 19 | 10 | |
| 20 | [Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway]. | 8 |
About Yong‐Zhan Zhen
Yong‐Zhan Zhen is a scholar working on Toxicology, Pharmacology and Aging, having authored 31 papers that have together received 482 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (6 papers) and Phytochemistry and biological activity of medicinal plants (6 papers). The work is most often cited by research in Toxicology (29 citations), Pharmacology (63 citations) and Hepatology (52 citations). Yong‐Zhan Zhen has collaborated with scholars based in China, Türkiye and United States. Frequent co-authors include Yajun Lin, Jie Wei, Gang Hu, Yong‐Su Zhen, Rong‐Guang Shao, Hongwei He, Gang Hu, Mao‐xu Ge, Yufang Zhao and Shuangshuang Zhao. Their work appears in journals such as Scientific Reports, British Journal of Pharmacology and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.